Subscribe to Newsletter

Advanced Medicine

Discovery & Development Drug Discovery

Lung Cancer Collaboration

| Jamie Irvine | 2 min read

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Formulation

T Cell Bright Spark

| 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Manufacture Advanced Medicine

Roundtable Discussion: Priorities for the Cell and Gene Field

| Stephanie Sutton

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Manufacture Advanced Medicine

Standardize for Success

| Mark Sawicki | 4 min read

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?

Discovery & Development Drug Discovery

Time for (CAR) T

| Stephanie Sutton | 6 min read

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

Manufacture Advanced Medicine

The ‘Tides are Turning

| Rob Coker | 5 min read

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

Discovery & Development Drug Discovery

To Be Precise

| Neil Ward | 3 min read

Better data brings new advances in our knowledge of genetics. PacBio VP Neil Ward explains how pharmacogenomics will accelerate precision medicine.

Manufacture Advanced Medicine

Stem Cells: The Next (Re)generation

| Rob Coker | 4 min read

CellProthera is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction

Manufacture Advanced Medicine

A Patient Story In The UK

| Stephanie Sutton | 2 min read

Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial.

Latest White Papers

How to Improve the Capturing of Antibody Fragments

| Contributed by Tosoh

Accelerate innovation and manufacturing to better serve patients

| Contributed by GenScript Probio

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine